The provided URLs and LinkedIn link do not match the company Elucid that is well-documented in the search results. However, based on the search results, Elucid is a Boston-based AI medical technology company. It offers PlaqueIQ, a software that provides objective and quantitative arterial analysis to help physicians diagnose and treat cardiovascular disease. The target audience is healthcare professionals, particularly cardiologists. The unique selling proposition is its FDA-cleared, histologically-validated imaging analysis software, which enables precise non-invasive diagnoses and treatment decisions[1][2][3]. If you are referring to a different company, please provide more context or details.